Latest International Expansion News

XRF Scientific Limited reported a record profit for FY25, driven by strong mining sector demand and international sales growth, alongside strategic acquisitions that bolster its market position.

XRF Scientific has reported a record full-year result for FY2025, with net profit rising 17% to $10.4 million and a 15% increase in its fully franked dividend. Strong global mining demand and recurring revenue streams underpin the company’s growth.

ARB Corporation Limited reported a 5.3% increase in sales revenue to $729.9 million for FY2025, driven by strong export growth and steady domestic sales, while profit after tax declined 5%. The company declared a special fully franked dividend amid ongoing US expansion efforts.

EcoGraf Limited has been granted its first Australian patent for its innovative HFfree® purification technology, reinforcing its position in the battery anode materials market. This milestone follows a recent breakthrough that cut purification costs by 25%, boosting the commercial potential of its purification facilities.

Audeara Limited reports a strong start to FY26 with a 46% revenue increase driven by Australian wholesale growth and a key international partnership. The company’s global ambitions are further highlighted by multiple export award nominations.

Kelly Partners Group Holdings posted a robust 24.5% revenue increase to $134.6 million in FY25, driven by strategic international expansions and acquisitions. The firm’s underlying profit after tax also rose 13%, underscoring its growing footprint across Australia, the US, and Ireland.

RocketBoots Limited has secured a significant trial contract with a major Australian retail bank, potentially expanding to a $234k SaaS rollout that could boost its recurring revenue and international ambitions.

Nick Scali Limited reported a resilient FY25 with solid sales growth in Australia and New Zealand, while UK operations continue to improve margins despite ongoing losses. The company declared a fully franked dividend and outlined plans for further expansion.

Nick Scali Limited reported a solid FY25 underlying profit of $62 million, driven by strong ANZ sales and online growth, while UK operations continue to struggle amid store refurbishments and brand repositioning.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.

Prophecy International Holdings has agreed to acquire Complexica in a transformative merger, creating Complexica Group Limited, an ASX-listed AI pure play software company with enhanced scale and growth potential.